Authors:
Klaudia Borbély Department of Radiology, Medical Imaging Centre, Semmelweis University, Budapest, Hungary

Search for other papers by Klaudia Borbély in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0000-0002-9380-757X
,
Hanna Balogh Department of Radiology, Medical Imaging Centre, Semmelweis University, Budapest, Hungary

Search for other papers by Hanna Balogh in
Current site
Google Scholar
PubMed
Close
,
Ilona Blanka Kardos Department of Radiology, Medical Imaging Centre, Semmelweis University, Budapest, Hungary

Search for other papers by Ilona Blanka Kardos in
Current site
Google Scholar
PubMed
Close
,
Daniele Mariastefano Fontanini Department of Diagnostic Radiology, Heart and Vascular Centre, Semmelweis University, Budapest, Hungary

Search for other papers by Daniele Mariastefano Fontanini in
Current site
Google Scholar
PubMed
Close
,
László Oláh Department of Medical Imaging, University of Debrecen, Debrecen, Hungary

Search for other papers by László Oláh in
Current site
Google Scholar
PubMed
Close
,
Ervin Berényi Department of Neurology, University of Debrecen, Debrecen, Hungary

Search for other papers by Ervin Berényi in
Current site
Google Scholar
PubMed
Close
, and
Pál Maurovich-Horvat Department of Radiology, Medical Imaging Centre, Semmelweis University, Budapest, Hungary

Search for other papers by Pál Maurovich-Horvat in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0000-0003-0885-736X
Open access

Abstract

Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is a hereditary vascular disorder inherited in an autosomal dominant manner. MRI plays a crucial role in the diagnosis and follow-up of patients. Characteristic MRI lesions include symmetric and bilateral white matter periventricular hyperintensities, lacunar infarcts and cerebral microbleeds. In our case report, we demonstrate a male patient with genetically confirmed CADASIL syndrome and the progression of symptoms with corresponding imaging findings throughout the years.

Abstract

Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is a hereditary vascular disorder inherited in an autosomal dominant manner. MRI plays a crucial role in the diagnosis and follow-up of patients. Characteristic MRI lesions include symmetric and bilateral white matter periventricular hyperintensities, lacunar infarcts and cerebral microbleeds. In our case report, we demonstrate a male patient with genetically confirmed CADASIL syndrome and the progression of symptoms with corresponding imaging findings throughout the years.

Introduction

Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is a hereditary vascular disorder inherited in an autosomal dominant manner with a prevalence of 1.93 per 100,000 adults [1]. It develops due to mutations of the epidermal growth factor-like repeat domain of the NOTCH3 gene located on chromosome 19p13 [2]. Factors that contribute to clinical suspicion include 1) Early-onset of clinical symptoms (40–50 years); 2) Recurrent transient ischemic attack episodes without the presence of stroke risk factors; 3) Episodes of lacunar infarcts leading to clinical presentations of pseudobulbar palsy and dementia; 4) Migraine with atypical aura; 5) Familial history of typical clinical manifestations [3]. Diagnostic methods include Magnetic Resonance Imaging (MRI), presence of Granular Osmophilic Material in capillary blood vessels on skin biopsy and molecular genetic analysis [4].

Case

In 2004 a 44-year-old male patient presented with clinical signs corresponding to left sided middle cerebral artery transient ischemic attack (speech disturbance, right sided hemi-sensory loss). Due to recurrent suspected transient ischemic episodes MRI investigation was performed. Baseline MRI findings showed symmetric and bilateral white matter hyperintensities in the periventricular regions seen on T2W-TSE and FLAIR sequences. Because of recurrent attacks of additional symptoms (headache, memory disturbance and vertigo) control MRI investigations were performed in the following years, in which lesions from the primary MRI scans were unchanged. In 2014 CADASIL syndrome was genetically proven. In the following period, the patient presented with symptoms typical for CADASIL syndrome including mild cognitive impairment with executive dysfunction, attention deficit, psychomotor retardation and mood disturbances. The patient's mood disturbances progressed to a maniac psychotic attack in 2019, in which he required psychiatric hospitalization. His neurological status in 2020 progressed compared to previous years with new neurological signs including: left sided hypoglossal paresis, bilateral lower extremity spasticity and frontal release signs. The latest MRI scan performed on the 22nd of September 2021 showed typical imaging characteristics of CADASIL syndrome. Lacunar infarcts and white matter hyperintensities were identified bilaterally in the subcortical and periventricular region on axial FLAIR images (Fig. 1). Predominant hyperintensities were also detected in the anterior pole of the temporal lobes and in the external capsules (Fig. 1). Hemosiderin depositions, which correspond to cerebral microbleeds, were observed in the cerebellum, brainstem, basal ganglia, and cerebral subcortical regions as focal signal loss on SWI sequence (Fig. 2).

Fig. 1.
Fig. 1.

Axial FLAIR images showing lacunar infarcts, symmetric and bilateral white matter hyperintensities emphasizing the anterior temporal lobe and external capsule regions

Citation: Imaging 14, 2; 10.1556/1647.2022.00059

Fig. 2.
Fig. 2.

Cerebral microbleeds in the basal ganglia, subcortical regions, brainstem, and cerebellum on SWI sequence

Citation: Imaging 14, 2; 10.1556/1647.2022.00059

Currently, our patient is being treated by the neurology department outpatient unit. Despite the progression of his clinical symptoms and MRI lesions the Mini Mental State Examination score only declined from 28 to 26 over the years. Due to his recent symptoms (staring spells, episodes of confusion without impaired consciousness) a new diagnostic workup for epilepsy was initiated and anti-epileptic medication was introduced.

Discussion

Our case demonstrates the difficulty in the diagnosis of CADASIL syndrome. Due to the wide differential diagnoses with similar and overlapping clinical and imaging manifestations CADASIL syndrome remains a highly underdiagnosed pathology. As displayed in our case, it may take years for physicians to assess and test for this entity. Diagnosis is further delayed when there is no typical family history of CADASIL syndrome.

Initially in our case, to rule out more common pathologies such as thromboembolic events, carotid doppler ultrasound, echocardiograms and ECGs were performed. Upon negative findings in these examinations, suspicion for less common disorders were raised and serial MRI images were performed. There are certain clinical and imaging features which can be used to differentiate CADASIL syndrome from pathologies with overlapping manifestations [3]. For example in comparison to multiple sclerosis, CADASIL syndrome more commonly displays temporo-polar lesions with sparing of the spinal cord [5]. CARASIL patients experience extra-neurological findings (spondylosis and alopecia) with earlier clinical manifestations and imaging findings [6]. This includes high signal intensity in the middle cerebellar peduncles and in the pons on T2W scans, known as the arc sign [7]. MRI features of Binswanger's disease include widespread diffuse white matter lesions and scattered multiple lacunes, but cerebral microbleeds are rarely observed [8]. Our case displayed these differences which enabled a greater likelihood of the diagnosis of CADASIL syndrome.

As of today there is no proven treatment for CADASIL syndrome. However, the work of a multidisciplinary team for the medical and psychological care of patients with CADASIL syndrome is crucial in improving their quality of life.

Authors' contribution

All persons who meet authorship criteria are listed as authors, and all authors certify that they have participated sufficiently in the work to take public responsibility for the content, including participation in the concept, writing or revision of the manuscript. Acquisition of images: KB, HB, IBK, DMF, EB, LO. Interpretation of literature: KB. Drafting the manuscript: KB, HB, IBK, DMF. Revising the manuscript critically for important intellectual content: PMH. Approval of the version of the manuscript to be published: PMH, KB, HB, IBK, DMF, EB, LO. This manuscript has not been published previously and is not under consideration for publication elsewhere.

Funding sources

No financial support was received for this case report.

Conflict of interest

Dr. Pál Maurovich-Horvat is the Editor-in-Chief of IMAGING, therefore the submission was handled by a different member of the editorial team.

References

  • [1]

    Choi J: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: A genetic cause of cerebral small vessel disease. Journal of Clinical Neurology 2010; 6(1): 1. https://doi.org/10.3988/jcn.2010.6.1.1.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [2]

    Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, et al.: Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996; 383(6602): 707710. https://doi.org/10.1038/383707a0.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [3]

    Di Donato I, Bianchi S, De Stefano N, Dichgans M, Dotti M, Duering M, et al.: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) as a model of small vessel disease: Update on clinical, diagnostic, and management aspects. BMC Medicine 2017; 15(1). https://doi.org/10.1186/s12916-017-0778-8.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [4]

    Peisker T, Musil L, Hrebicek M, Vlaskova H, Cihelkova I, Bartos A: Clinical spectrum in CADASIL family with a new mutation. Biomedical Papers 2013; 157(4): 379382. https://doi.org/10.5507/bp.2013.055.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [5]

    Joshi S, Yau W, Kermode A: CADASIL mimicking multiple sclerosis: The importance of clinical and MRI red flags. Journal of Clinical Neuroscience 2017; 35: 7577. https://doi.org/10.1016/j.jocn.2016.09.025.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [6]

    Yanagawa S, Ito N, Arima K, Ikeda S: Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. Neurology 2002; 58(5): 817820. https://doi.org/10.1212/wnl.58.5.817.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [7]

    Nozaki H, Sekine Y, Fukutake T, Nishimoto Y, Shimoe Y, Shirata A, et al.: Characteristic features and progression of abnormalities on MRI for CARASIL. Neurology 2015; 85(5): 459463. https://doi.org/10.1212/wnl.0000000000001803.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [8]

    Román G, Erkinjuntti T, Wallin A, Pantoni L, Chui H: Subcortical ischaemic vascular dementia. The Lancet Neurology 2002; 1(7): 426436. https://doi.org/10.1016/s1474-4422(02)00190-4.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [1]

    Choi J: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: A genetic cause of cerebral small vessel disease. Journal of Clinical Neurology 2010; 6(1): 1. https://doi.org/10.3988/jcn.2010.6.1.1.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [2]

    Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, et al.: Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996; 383(6602): 707710. https://doi.org/10.1038/383707a0.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [3]

    Di Donato I, Bianchi S, De Stefano N, Dichgans M, Dotti M, Duering M, et al.: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) as a model of small vessel disease: Update on clinical, diagnostic, and management aspects. BMC Medicine 2017; 15(1). https://doi.org/10.1186/s12916-017-0778-8.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [4]

    Peisker T, Musil L, Hrebicek M, Vlaskova H, Cihelkova I, Bartos A: Clinical spectrum in CADASIL family with a new mutation. Biomedical Papers 2013; 157(4): 379382. https://doi.org/10.5507/bp.2013.055.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [5]

    Joshi S, Yau W, Kermode A: CADASIL mimicking multiple sclerosis: The importance of clinical and MRI red flags. Journal of Clinical Neuroscience 2017; 35: 7577. https://doi.org/10.1016/j.jocn.2016.09.025.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [6]

    Yanagawa S, Ito N, Arima K, Ikeda S: Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. Neurology 2002; 58(5): 817820. https://doi.org/10.1212/wnl.58.5.817.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [7]

    Nozaki H, Sekine Y, Fukutake T, Nishimoto Y, Shimoe Y, Shirata A, et al.: Characteristic features and progression of abnormalities on MRI for CARASIL. Neurology 2015; 85(5): 459463. https://doi.org/10.1212/wnl.0000000000001803.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [8]

    Román G, Erkinjuntti T, Wallin A, Pantoni L, Chui H: Subcortical ischaemic vascular dementia. The Lancet Neurology 2002; 1(7): 426436. https://doi.org/10.1016/s1474-4422(02)00190-4.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Collapse
  • Expand
The author instruction is available in PDF.
Please, download the file from HERE.

 

The Open Access statement together with the description of the Copyright and License Policy are available in PDF.
Please, download the file from HERE.

 

Chair of the Editorial Board:
Béla MERKELY (Semmelweis University, Budapest, Hungary)

Editor-in-Chief:
Pál MAUROVICH-HORVAT (Semmelweis University, Budapest, Hungary)

Deputy Editor-in-Chief:
Viktor BÉRCZI (Semmelweis University, Budapest, Hungary)

Executive Editor:
Charles S. WHITE (University of Maryland, USA)

Deputy Editors:
Gianluca PONTONE (Department of Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS, Milan, Italy)
Michelle WILLIAMS (University of Edinburgh, UK)

Senior Associate Editors:
Tamás Zsigmond KINCSES (University of Szeged, Hungary)
Hildo LAMB (Leiden University, The Netherlands)
Denisa MURARU (Istituto Auxologico Italiano, IRCCS, Milan, Italy)
Ronak RAJANI (Guy’s and St Thomas’ NHS Foundation Trust, London, UK)

Associate Editors:
Andrea BAGGIANO (Department of Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS, Milan, Italy)
Fabian BAMBERG (Department of Radiology, University Hospital Freiburg, Germany)
Péter BARSI (Semmelweis University, Budapest, Hungary)
Theodora BENEDEK (University of Medicine, Pharmacy, Sciences and Technology, Targu Mures, Romania)
Ronny BÜCHEL (University Hospital Zürich, Switzerland)
Filippo CADEMARTIRI (SDN IRCCS, Naples, Italy) Matteo CAMELI (University of Siena, Italy)
Csilla CELENG (University of Utrecht, The Netherlands)
Edit DÓSA (Semmelweis University, Budapest, Hungary)
Tilman EMRICH (University Hospital Mainz, Germany)

Marco FRANCONE (La Sapienza University of Rome, Italy)
Viktor GÁL (OrthoPred Ltd., Győr, Hungary)
Alessia GIMELLI (Fondazione Toscana Gabriele Monasterio, Pisa, Italy)
Tamás GYÖRKE (Semmelweis Unversity, Budapest)
Fabian HYAFIL (European Hospital Georges Pompidou, Paris, France)
György JERMENDY (Bajcsy-Zsilinszky Hospital, Budapest, Hungary)
Pál KAPOSI (Semmelweis University, Budapest, Hungary)
Mihaly KÁROLYI (University of Zürich, Switzerland)
Lajos KOZÁK (Semmelweis University, Budapest, Hungary)
Mariusz KRUK (Institute of Cardiology, Warsaw, Poland)
Zsuzsa LÉNARD (Semmelweis University, Budapest, Hungary)
Erica MAFFEI (ASUR Marche, Urbino, Marche, Italy)
Robert MANKA (University Hospital, Zürich, Switzerland)
Saima MUSHTAQ (Cardiology Center Monzino (IRCCS), Milan, Italy)
Gábor RUDAS (Semmelweis University, Budapest, Hungary)
Balázs RUZSICS (Royal Liverpool and Broadgreen University Hospital, UK)
Christopher L SCHLETT (Unievrsity Hospital Freiburg, Germany)
Bálint SZILVESZTER (Semmelweis University, Budapest, Hungary)
Richard TAKX (University Medical Centre, Utrecht, The Netherlands)
Ádám TÁRNOKI (National Institute of Oncology, Budapest, Hungary)
Dávid TÁRNOKI (National Institute of Oncology, Budapest, Hungary)
Ákos VARGA-SZEMES (Medical University of South Carolina, USA)
Hajnalka VÁGÓ (Semmelweis University, Budapest, Hungary)
Jiayin ZHANG (Department of Radiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China)

International Editorial Board:

Gergely ÁGOSTON (University of Szeged, Hungary)
Anna BARITUSSIO (University of Padova, Italy)
Bostjan BERLOT (University Medical Centre, Ljubljana, Slovenia)
Edoardo CONTE (Centro Cardiologico Monzino IRCCS, Milan)
Réka FALUDI (University of Szeged, Hungary)
Andrea Igoren GUARICCI (University of Bari, Italy)
Marco GUGLIELMO (Department of Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS, Milan, Italy)
Kristóf HISRCHBERG (University of Heidelberg, Germany)
Dénes HORVÁTHY (Semmelweis University, Budapest, Hungary)
Julia KARADY (Harvard Unversity, MA, USA)
Attila KOVÁCS (Semmelweis University, Budapest, Hungary)
Riccardo LIGA (Cardiothoracic and Vascular Department, Università di Pisa, Pisa, Italy)
Máté MAGYAR (Semmelweis University, Budapest, Hungary)
Giuseppe MUSCOGIURI (Centro Cardiologico Monzino IRCCS, Milan, Italy)
Anikó I NAGY (Semmelweis University, Budapest, Hungary)
Liliána SZABÓ (Semmelweis University, Budapest, Hungary)
Özge TOK (Memorial Bahcelievler Hospital, Istanbul, Turkey)
Márton TOKODI (Semmelweis University, Budapest, Hungary)

Managing Editor:
Anikó HEGEDÜS (Semmelweis University, Budapest, Hungary)

Pál Maurovich-Horvat, MD, PhD, MPH, Editor-in-Chief

Semmelweis University, Medical Imaging Centre
2 Korányi Sándor utca, Budapest, H-1083, Hungary
Tel: +36-20-663-2485
E-mail: maurovich-horvat.pal@med.semmelweis-univ.hu

Indexing and Abstracting Services:

  • WoS Emerging Science Citation Index
  • Scopus
  • DOAJ

2023  
Web of Science  
Journal Impact Factor 0.7
Rank by Impact Factor Q3 (Medicine, General & Internal)
Journal Citation Indicator 0.09
Scopus  
CiteScore 0.7
CiteScore rank Q4 (Medicine miscellaneous)
SNIP 0.151
Scimago  
SJR index 0.181
SJR Q rank Q4

Imaging
Publication Model Gold Open Access
Submission Fee none
Article Processing Charge none
Subscription Information Gold Open Access

Imaging
Language English
Size A4
Year of
Foundation
2020 (2009)
Volumes
per Year
1
Issues
per Year
2
Founder Akadémiai Kiadó
Founder's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 2732-0960 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Apr 2024 0 15 18
May 2024 0 11 9
Jun 2024 0 35 8
Jul 2024 0 36 16
Aug 2024 0 46 26
Sep 2024 0 18 12
Oct 2024 0 0 0